|
|
| Research article summary (published 16 Sep 2007): |
Effectiveness of mobile and internet intervention in patients with obese type 2 diabetes.
Full Abstract
PURPOSE:
The present study evaluated whether an intervention using the SMS by personal cellular phone and internet would improve the levels of plasma glucose of obese type 2 diabetes at 3, 6, 9, and 12 months.
METHODS:
This is a quasi-experimental design with pre- and follow-up tests. Participants were recruited from the endocrinology outpatient department of tertiary care hospital located in an urban city of South Korea. Eighteen patients were randomly assigned to an intervention group and 16 to a control group. The goal of the intervention was to decrease body weight and keep blood glucose concentrations close to the normal range. Patients were requested to record their blood glucose level in a weekly diary on the website by personal cellular phones or computer internet. The researcher sent optimal recommendations to each patient, by both the cellular phone and the Internet weekly. The intervention was applied for 1 year.
RESULTS:
Glycosylated hemoglobin (HbA(1)c) decreased 1.22 percentage points at 3 months, 1.09 percentage points at 6 months, 1.47 percentage points at 9 months, and 1.49 percentage points at 12 months compared with baseline in the intervention group (all time points, p<0.05). The percentage change in the control group was, however, not significant. Patients in the intervention group had a decrease of 2-h post-prandial test (2HPPT) of 120.1mg/dl at 3 months, 58.9 mg/dl at 6 months, 62.0mg/dl at 9 months, and 102.9 mg/dl at 12 months compared with baseline (all time points, p<0.05). The mean change in the control group was, however, not significant.
CONCLUSION:
This web-based intervention using SMS of personal cellular phone and Internet improved HbA(1)c and 2HPPT at 3, 6, 9, and 12 months in patients with obese type 2 diabetes.
Learn Faster Today Improve your study skills
Author information
Author/s: Kim, Suk-Il (SI); Kim, Hee-Seung (HS);
Affiliation: Department of Preventive Medicine, College of Medicine, The Catholic University, Seoul, South Korea.
Journal and publication information
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal: International journal of medical informatics (Int J Med Inform), published in Ireland. (Language: eng)
Reference: 2008-Jun; vol 77 (issue 6) : pp 399-404
Dates: Created 2008/04/25; Completed 2008/06/27;
PMID: 17881285, status: MEDLINE (last retrieval date: 11/6/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
These are the highest related articles currently in the database:
- Evaluation of accessibility and use of new communication technologies in patients with type 1 diabetes mellitus.
29 Nov 2002 - A short message service by cellular phone in type 2 diabetic patients for 12 months.
5 Nov 2007 - Feasibility of a mobile phone-based data service for functional insulin treatment of type 1 diabetes mellitus patients.
29 Dec 2007 - Lifestyle interventions are cost-effective in people with different levels of diabetes risk: results from a modeling study.
30 Dec 2006 - Cost-effectiveness of rosiglitazone oral combination for the treatment of type 2 diabetes in Germany.
30 Dec 2005 - A nurse short message service by cellular phone in type-2 diabetic patients for six months.
30 May 2007 - Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain.
30 Dec 2005 - Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.
11 Aug 2007 - Cost-effectiveness of rosiglitazone combination therapy for the treatment of type 2 diabetes mellitus in the UK.
30 Dec 2005 - Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors.
30 Mar 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.